Associations between alcohol consumption and selected cytokines in a Swiss population-based sample (CoLaus study)

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 245-250

  Marques Vidal, Pedro ^a   Bochud, Murielle ^a   Bastardot, François ^b   von Känel, Roland ^c   Ferrero, François ^d   Gaspoz, Jean Michel ^d   Paccaud, Fred ^a   Urwyler, Adrian ^e   Lüscher, Thomas ^f   Hock, Christoph ^g   Waeber, Gérard ^b   Preisig, Martin ^b   Vollenweider, Peter ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e University Hospital Zürich ^*

^f UNIVERSITY OF ZURICH   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Alcohol consumption; Beer; IL 1 ; IL 6; Inflammation; Population study; TNF ; Wine

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BEER; BLOOD LEVEL; FEMALE; HUMAN; LIFESTYLE; MALE; POPULATION; PRIORITY JOURNAL; WINE;

EID: 84859873854     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.011     Document Type: Article

References (31)

1. Marques-Vidal P., Montaye M., Arveiler D., et al. Alcohol consumption and cardiovascular disease: differential effects in France and Northern Ireland. The PRIME study. Eur J Cardiovasc Prev Rehabil 2004, 11:336-343.
2. Imhof A., Woodward M., Doering A., et al. Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J 2004, 25:2092-2100.
3. Danesh J., Kaptoge S., Mann A.G., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008, 5:e78.
4. Hoffmeister A., Imhof A., Rothenbacher D., et al. Moderater Alkoholkonsum und Plasmakonzentration sensitiver Entzundungsmarker. Hinweise auf einen atheroprotektiven Zusammenhang [Moderate alcohol consumption and plasma concentration of sensitive markers of inflammation. Comment on an atheroprotective relationship]. Dtsch Med Wochenschr 2003, 128:2237-2241.
5. Sacanella E., Vázquez-Agell M., Mena M.P., et al. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am J Clin Nutr 2007, 86:1463-1469.
6. Volpato S., Pahor M., Ferrucci L., et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 2004, 109:607-612.
7. González-Quintela A., Campos J., Loidi L., et al. Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol 2008, 42:513-518.
8. Watzl B., Bub A., Pretzer G., et al. Daily moderate amounts of red wine or alcohol have no effect on the immune system of healthy men. Eur J Clin Nutr 2004, 58:40-45.
9. Foerster M., Marques-Vidal P., Gmel G., et al. Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol 2009, 103:361-368.
10. Firmann M., Mayor V., Vidal P.M., et al. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008, 8:6.
11. Dufour M.C. What is moderate drinking? Defining drinks and drinking levels. Alcohol Res Health 1999, 23:5-14.
12. Giovannucci E., Colditz G., Stampfer M.J., et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 1991, 133:810-817.
13. Bernstein M., Morabia A., Costanza M.C., et al. Equilibre nutritionnel de l'alimentation de la population adulte résidant a Genève [Nutritional balance of the diet of the adult residents of Geneva]. Soz Praventivmed 1994, 39:333-344.
14. Morabia A., Bernstein M., Kumanyika S., et al. Développement et validation d'un questionnaire alimentaire semi-quantitatif à partir d'une enquête de population [Development and validation of a semi-quantitative food questionnaire based on a population survey]. Soz Praventivmed 1994, 39:345-369.
15. Skeppholm M., Wallén N.H., Blombäck M., Kallner A. Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations?. Clin Chem Lab Med 2008, 46:1175-1179.
16. Vignali D.A. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000, 243:243-255.
17. Marques-Vidal P., Bochud M., Bastardot F., et al. Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study). PLoS One 2011, 6:e21002.
18. Lean M.E., Han T.S., Morrison C.E. Waist circumference as a measure for indicating need for weight management. BMJ 1995, 311:158-161.
19. Oka H., Ikeda S., Koga S., Miyahara Y., Kohno S. Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. Heart Vessels 2008, 23:249-256.
20. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
21. Hornung R., Reed L. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990, 5:46-51.
22. Olholm J., Paulsen S.K., Cullberg K.B., Richelsen B., Pedersen S.B. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes (Lond) 2010.
23. Bertelli A., Migliori M., Bertelli A.A., et al. Effect of some white wine phenols in preventing inflammatory cytokine release. Drugs Exp Clin Res 2002, 28(1):11-15.
24. Laso F.J., Vaquero J.M., Almeida J., Marcos M., Orfao A. Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: relationship with ethanol intake and liver disease. Cytometry B Clin Cytom 2007, 72:408-415.
25. Nicolaou C., Chatzipanagiotou S., Tzivos D., et al. Serum cytokine concentrations in alcohol-dependent individuals without liver disease. Alcohol 2004, 32:243-247.
26. Pai J.K., Hankinson S.E., Thadhani R., et al. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 2006, 186:113-120.
27. Tousoulis D., Ntarladimas I., Antoniades C., et al. Acute effects of different alcoholic beverages on vascular endothelium, inflammatory markers and thrombosis fibrinolysis system. Clin Nutr 2008, 27:594-600.
28. Vázquez-Agell M., Sacanella E., Tobias E., et al. Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J Nutr 2007, 137:2279-2284.
29. Sierksma A., Patel H., Ouchi N., et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 2004, 27:184-189.
30. Tolonen H, Koponen P, Aromaa A, et al. Review of health examination surveys in Europe. Helsinki, Finland: National Public Health Institute (KTL); 2008. Report No.: B18/2008.
31. Costanzo S., Di Castelnuovo A., Donati M.B., Iacoviello L., de Gaetano G. Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease. Circulation 2010, 121:1951-1959.